<!DOCTYPE html>
<meta charset="utf8" />
<html>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jsdiff/5.2.0/diff.min.js"></script>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header><h1>QuiVoteQuoi?</h1></header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>2019 discharge: Innovative Medicines Initiative (IMI) Joint Undertaking</h2>
            
            <ul>
                
                <li><a href="/vote/129659">A9-0113/2021 - Ryszard Czarnecki - Am 4</a></li>
                
                <li><a href="/vote/129660">A9-0113/2021 - Ryszard Czarnecki - Am 5</a></li>
                
                <li><a href="/vote/129661">A9-0113/2021 - Ryszard Czarnecki - Am 1</a></li>
                
                <li><a href="/vote/129662">A9-0113/2021 - Ryszard Czarnecki - Am 2</a></li>
                
                <li><a href="/vote/129663">A9-0113/2021 - Ryszard Czarnecki - Am 3</a></li>
                
                <li><a href="/vote/130215">Décharge 2019 : entreprise commune Initiative en matière de médicaments innovants 2 - 2019 discharge: Innovative Medicines Initiative 2 Joint Undertaking - Entlastung 2019: Gemeinsames Unternehmen „Initiative Innovative Arzneimittel 2” - A9-0113/2021 - Ryszard Czarnecki - § 10</a></li>
                
                <li><a href="/vote/130216">A9-0113/2021 - Ryszard Czarnecki - § 14</a></li>
                
                <li><a href="/vote/130218">A9-0113/2021 - Ryszard Czarnecki - § 19/1</a></li>
                
                <li><a href="/vote/130219">A9-0113/2021 - Ryszard Czarnecki - § 19/2</a></li>
                
                <li><a href="/vote/130221">A9-0113/2021 - Ryszard Czarnecki - § 21/1</a></li>
                
                <li><a href="/vote/130222">A9-0113/2021 - Ryszard Czarnecki - § 21/2</a></li>
                
                <li><a href="/vote/130663">Décharge 2019 : entreprise commune Initiative en matière de médicaments innovants 2 - 2019 discharge: Innovative Medicines Initiative 2 Joint Undertaking - Entlastung 2019: Gemeinsames Unternehmen „Initiative Innovative Arzneimittel 2” - A9-0113/2021 - Ryszard Czarnecki - Propositions de décision</a></li>
                
                <li><a href="/vote/130897">Décharge 2019 : entreprise commune Initiative en matière de médicaments innovants 2 - 2019 discharge: Innovative Medicines Initiative 2 Joint Undertaking - Entlastung 2019: Gemeinsames Unternehmen „Initiative Innovative Arzneimittel 2” - A9-0113/2021 - Rszard Czarnecki - Proposition de résolution</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>